ImmuneSpec provides a broad range of services that meet the specific needs of pharmaceutical and biotech companies. Our platform supports clients in various fields throughout the different stages of the biotherapeutic development process.
With ImmuneSpec, you can access state-of-the-art facilities and leverage our in-depth expertise in immunopeptidomics. We offer a unique combination of techniques and knowledge to obtain immunogenic data, which can significantly improve the design and development of biotherapeutics.
Simplify the drug development process by identifying immunogenic areas early on.
An extensive immunogenic profile of target compounds obtained by state-of-the-art MAPPS analysis helps to ensure the project stays within budget and meets timelines. It promotes a robust R&D strategy and enables safe monitoring of clinical trials by facilitating the selection of high-quality leads and providing deep insights into the compound's safety and efficacy features.
An extensive determination of the immunogenic profile of a biotherapeutic facilitates the evaluation of its safety and efficacy.
ImmuneSpec's state-of-the-art platform generates a thorough understanding of a compound's immunogenic areas. It provides the necessary data to demonstrate how a biotherapeutic aligns with regulatory requirements, thus facilitating approval for market access.
Institute of Tropical Medicine Antwerp
An advanced drug development process.
The benefits of immunogenic profiling.
The identification of a compound's immunogenic areas shows beneficial effects at different stages of the drug development process.